Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (Q40171279)
Jump to navigation
Jump to search
scientific article published on 13 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia |
scientific article published on 13 February 2007 |
Statements
1 reference
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (English)
1 reference
1 reference
Georgia Metzgeroth
1 reference
Giovanni Martinelli
1 reference
Emanuela Ottaviani
1 reference
Jane Apperley
1 reference
Daniela Cilloni
1 reference
Enrico Gottardi
1 reference
Philipp Erben
1 reference
Jelena V Jovanovic
1 reference
Joannah Score
1 reference
Katherine Waghorn
1 reference
Helena Popp
1 reference
Christoph Walz
1 reference
Ellen Solomon
1 reference
Finella Brito-Babapulle
1 reference
Rüdiger Hehlmann
1 reference
Nicholas C P Cross
1 reference
Andreas Reiter
1 reference
David Grimwade
1 reference
13 February 2007
1 reference
1 reference
109
1 reference
11
1 reference
4635-4640
1 reference
Identifiers
1 reference
1 reference